Related Experiment Video
Updated: May 10, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Sclerostin, an osteocytes-derived bone-forming inhibitor
Krzysztof H Włodarski1, Ryszard Galus, Aniela Brodzikowska
1Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland. krzysztof.wlodarski@wum.edu.pl
Abstract:
Sclerostin is a recently identified glycoprotein expressed and synthesized by osteocytes. It is a powerful inhibitor of osteoblasts proliferation and differentiation. Sclerostin inhibits the Wnt signaling, the main trigger of osteoblasts activity. Osteocytes on response to a mechanical loading decrease the synthesis of sclerostin enabling in osteoblasts the Wnt signaling and promote their bone-forming activity. This explains why mechanical loading induces bone formation. Monoclonal antibodies directed against sclerostin reverses sclerostin induced bone catabolic effect and are promising tool in prevention and treatment of osteoporosis in human.
Insights
Sclerostin, a protein made by osteocytes, inhibits bone formation by blocking Wnt signaling. Reducing sclerostin, through mechanical loading or antibodies, promotes bone growth and may treat osteoporosis.
Area of Science:
- Bone biology
- Cell signaling
- Osteoporosis research
Background:
- Sclerostin is a glycoprotein produced by osteocytes.
- It acts as a potent inhibitor of osteoblast proliferation and differentiation.
- Sclerostin negatively regulates the Wnt signaling pathway, crucial for osteoblast activity.
Purpose of the Study:
- To explain the mechanism by which mechanical loading stimulates bone formation.
- To highlight the role of sclerostin in bone metabolism.
- To introduce sclerostin-targeting monoclonal antibodies as a therapeutic strategy for osteoporosis.
Main Methods:
- Investigated the role of sclerostin in osteocyte-osteoblast communication.
- Examined the effect of mechanical loading on sclerostin synthesis.
- Reviewed the impact of monoclonal antibodies against sclerostin on bone remodeling.
Main Results:
- Mechanical loading reduces osteocyte sclerostin synthesis, thereby activating Wnt signaling and promoting osteoblast bone-forming activity.
- Sclerostin directly inhibits osteoblast proliferation and differentiation.
- Monoclonal antibodies against sclerostin counteract sclerostin's bone-catabolic effects.
Conclusions:
- Sclerostin is a key mediator linking mechanical stimuli to bone formation.
- Targeting sclerostin with monoclonal antibodies offers a promising therapeutic approach for osteoporosis by enhancing bone formation.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Bone Remodeling
Skeleton and Calcium Homeostasis
The Bone Matrix
